Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01136824 · ClinicalTrials.gov registry record
Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 11
- Enrollment target
NCT01136824: Completed study, sponsored by University of Pittsburgh.
NCT01136824 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01136824 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Assessments (survey data) in this study are designed to sample the symptom burden of patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no change in the treatment plan for these patients.
Interventions
- OTHER Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-05 |
What the finished NCT01136824 record still lists
NCT01136824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT01136824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01136824 about?
NCT01136824 is a clinical study titled "Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden". Assessments (survey data) in this study are designed to sample the symptom burden of patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no change in the treatment plan for these patients.
What is the current status of trial NCT01136824?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2010-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01136824?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT01136824?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia